Upadacitinib

Therapeutic Group

Immunomodulators

Indication Dosage

Indication:

Upadacitinib is a Janus kinase (JAK) inhibitor used for:

  1. Rheumatoid Arthritis (RA) – Joint pain and swelling.
  2. Psoriatic Arthritis (PsA) – Joint pain with skin issues.
  3. Ankylosing Spondylitis (AS) – Back and spine pain.
  4. Non-Radiographic Axial Spondyloarthritis (nr-axSpA) – Spine pain with inflammation.
  5. Atopic Dermatitis (Eczema) – Severe skin itching and rashes.
  6. Ulcerative Colitis (UC) & Crohn’s Disease (CD) –  Inflammatory bowel diseases.

Dosage:

For Arthritis (RA, PsA, AS, nr-axSpA): 15 mg once daily.

For Severe Eczema (Atopic Dermatitis):

  • Adults: 15 mg or 30 mg once daily.
  • Children (≥12 years): 15 mg if weight is 40-60 kg, 30 mg if above 60 kg.

For Ulcerative Colitis & Crohn’s Disease:

  • Starting dose: 45 mg once daily for 8 weeks.
  • After 8 weeks: 15 mg or 30 mg once daily.

Content

  • Tab 15mg, 30mg, 45mg: Upadacitinib 15mg, 30mg, 45mg

Pregnancy

Not Recommended

Stability

  • Janus Kinase (JAK) Inhibitor

Contra Indications

  • Upadacitinib is contraindicated in severe infections (TB, sepsis), liver disease, history of blood clots, severe heart conditions, pregnancy, breastfeeding, and live vaccine use.

Precautions

  • Upadacitinib is contraindicated in severe infections (TB, sepsis), liver disease, history of blood clots, severe heart conditions, pregnancy, breastfeeding, and live vaccine use.

Lactation

  • Not Recommended

Side Effects

  • Infections (TB, herpes, pneumonia)
  • Headache
  • Nausea
  • Fatigue
  • Acne
  • Increased Liver Enzymes
  • High Blood Pressure
  • Cough

Available Brands